Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Feb;93(2):453–461. doi: 10.1111/j.1476-5381.1988.tb11453.x

14 beta-Hydroxyprogesterone binds to the digitalis receptor, inhibits the sodium pump and enhances cardiac contractility.

D Bose 1, D Elliott 1, T Kobayashi 1, J F Templeton 1, V P Kumar 1, F S LaBella 1
PMCID: PMC1853820  PMID: 3359115

Abstract

1. Certain derivatives of progesterone are potent inhibitors of high affinity, specific binding of 3H-cardiac glycosides. The steroids interact at the cardiac glycoside site on Na,K-ATPase and inhibit the enzyme (the sodium pump) in cardiac and other tissues. However, the active congeners identified previously have been, unlike the cardiac glycosides, predominantly cardiodepressant. 2. Because a 14 beta-hydroxy substituent is an important determinant of activity of the cardiotonic cardiac glycosides, we synthesized 14 beta-hydroxyprogesterone. This derivative has about one-tenth the potency of the aglycone, ouabagenin, in a [3H]-ouabain binding assay. 3. Like ouabagenin, but in contrast to the cardiodepressant congeners of progesterone, 14 beta-hydroxyprogesterone consistently elicited positive inotropy in isolated cardiac muscle and enhanced both the magnitude and frequency of fluctuations in scattered light (an index of oscillatory intracellular release of calcium). 4. Thus, at least one hydroxylated derivative (and putative endogenous metabolite) of progesterone, mimics the cardiac effects of cardiac glycosides including enhanced contractility.

Full text

PDF
453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bihler I., LaBella F. S., Sawh P. C. Chlormadinone acetate, a progesterone derivative that binds to the digitalis receptor, inhibits the sodium pump in the isolated rat diaphragm. Can J Physiol Pharmacol. 1985 Jan;63(1):44–47. doi: 10.1139/y85-007. [DOI] [PubMed] [Google Scholar]
  2. Bonaccorsi A., Hermsmeyer K., Aprigliano O., Smith C. B., Bohr D. F. Mechanism of potassium relaxation of arterial muscle. Blood Vessels. 1977;14(5):261–276. doi: 10.1159/000158133. [DOI] [PubMed] [Google Scholar]
  3. Bose D., Innes I. R. The role of sodium pump in the inhibition of smooth muscle responsiveness to agonists during potassium restoration. Br J Pharmacol. 1973 Nov;49(3):466–479. doi: 10.1111/j.1476-5381.1973.tb17257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyechko G., Bose D. A versatile computer-controlled biological stimulus sequencer. J Pharmacol Methods. 1984 Aug;12(1):45–52. doi: 10.1016/0160-5402(84)90005-6. [DOI] [PubMed] [Google Scholar]
  5. Chow E., Kim R. S., Labella F. S., Queen G. Ouabain receptor binding of hydroxyprogesterone derivatives. Br J Pharmacol. 1979 Nov;67(3):345–352. doi: 10.1111/j.1476-5381.1979.tb08686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gelbart A., Thomas R. Cardenolide analogues. 7. Synthesis and biological activity of some new steroidal guanylhydrazones. J Med Chem. 1978 Mar;21(3):284–288. doi: 10.1021/jm00201a010. [DOI] [PubMed] [Google Scholar]
  7. Hnatowich M., Labella F. Endogenous digitalis-like factors: in vitro comparison of biological and immunological activities of peptide and steroid candidates. Eur J Pharmacol. 1984 Nov 27;106(3):567–575. doi: 10.1016/0014-2999(84)90060-8. [DOI] [PubMed] [Google Scholar]
  8. LaBella F. S., Bihler I., Kim R. S. Progesterone derivative binds to cardiac ouabain receptor and shows dissociation between sodium pump inhibition and increased contractile force. Nature. 1979 Apr 5;278(5704):571–573. doi: 10.1038/278571a0. [DOI] [PubMed] [Google Scholar]
  9. LaBella F. S., Bihler I., Kim R. S. Progesterone derivatives that bind to the digitalis receptor: effects on 86Rb uptake and contractility in the isolated guinea pig heart. Can J Physiol Pharmacol. 1984 Sep;62(9):1057–1064. doi: 10.1139/y84-177. [DOI] [PubMed] [Google Scholar]
  10. LaBella F. S., Bihler I., Templeton J., Kim R. S., Hnatowich M., Rohrer D. Progesterone derivatives that bind to the digitalis receptor: effects on Na+,K+-ATPase and isolated tissues. Fed Proc. 1985 Sep;44(12):2806–2811. [PubMed] [Google Scholar]
  11. Lappé D. L., Lakatta E. G. Intensity fluctuation spectroscopy monitors contractile activation in "resting" cardiac muscle. Science. 1980 Mar 21;207(4437):1369–1371. doi: 10.1126/science.7355295. [DOI] [PubMed] [Google Scholar]
  12. Rafuse P. E., Almeida A. F., Kwan S. F., Smith P. A. Effects of mammalian brain extracts and chlormadinone acetate on neuronal Na+,K+-ATPase and electrogenic Na+,K+-pump activity in vitro. Brain Res. 1985 Sep 30;344(1):33–40. doi: 10.1016/0006-8993(85)91186-2. [DOI] [PubMed] [Google Scholar]
  13. Schulz R., Wüster M., Krenss H., Herz A. Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens. Mol Pharmacol. 1980 Nov;18(3):395–401. [PubMed] [Google Scholar]
  14. TANZ R. D. INOTROPIC EFFECTS OF CERTAIN STEROIDS UPON HEART MUSCLE. Rev Can Biol. 1963 Jun;22:147–163. [PubMed] [Google Scholar]
  15. Taylor G. S., Paton D. M., Daniel E. E. Characteristics of electrogenic sodium pumping in rat myometrium. J Gen Physiol. 1970 Sep;56(3):360–375. doi: 10.1085/jgp.56.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Temma K., Ng Y. C., Brody T. M., Akera T. Effects of progesterone derivatives on sodium pump activity and force of myocardial contraction in isolated guinea pig heart. Res Commun Chem Pathol Pharmacol. 1983 Jul;41(1):51–63. [PubMed] [Google Scholar]
  17. Templeton J. F., Kumar V. P., Cote D., Bose D., Elliott D., Kim R. S., LaBella F. S. Progesterone derivatives that bind to the digitalis receptor: synthesis of 14 beta-hydroxyprogesterone. A novel steroid with positive inotropic activity. J Med Chem. 1987 Aug;30(8):1502–1505. doi: 10.1021/jm00391a038. [DOI] [PubMed] [Google Scholar]
  18. Wehling M., Schwartz A., Whitmer K., Grupp G., Grupp I. L., Wallick E. T. Interaction of chlormadinone acetate with the ouabain binding site of Na+,K+-ATPase. Mol Pharmacol. 1981 Nov;20(3):551–557. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES